Clin2
NCT07407569Worth exploringRecruiting

HPV vaccine study for women with HPV16

Human Papilloma Virus Infection Type 16

Treatments studied

Gardasil-9

Part of Infections clinical trials.

This study tests how HPV antibodies work in urine samples from women with HPV16 before and after they get the HPV vaccine (Gardasil 9). It helps researchers understand how the vaccine protects against HPV.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
50 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • Women aged 18 to 45
  • Must have tested positive for HPV16 (with or without other HPV types)
  • No current or recent (last 12 months) genital warts or lesions needing treatment
  • Never received an HPV vaccine before
  • Not pregnant and willing to use birth control during the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06582654Recruiting
Antibody detection in first-void urine

This study looks at a new way to detect HPV antibodies in a urine sample. It is for people who have received the HPV vaccine to help improve testing.

Edegem, Antwerp
NCT06052696Not yet recruiting· Phase 4
HPV vaccine after treatment for vulvar high-grade lesions

This trial tests whether getting the HPV vaccine after treatment for vulvar high-grade lesions can help prevent the lesions from coming back. It is for women who have not been vaccinated before and are about to have treatment for this condition.

Rotterdam
NCT05334706Recruiting· Phase 4
Vaccine study to lower HPV spread in HPV-positive women

This Phase 4 study tests whether a 9-type HPV vaccine (9vHPV) can reduce how infectious HPV is and lower the chance of HPV spreading in women who already have HPV16 and/or HPV18. It focuses on specific HPV-positive women recently diagnosed and compares what happens after vaccination.

L'Hospitalet de Llobregat, Catalonia
NCT05829629Recruiting· Phase 1
Test of an HPV vaccine-like treatment for HPV16 in women

This Phase 1 study tests FluBHPVE6E7, a new treatment designed to help the immune system respond to HPV16. It mainly checks safety and the best dose, and may help your body clear or control HPV over time.

Bratislava
NCT05262010Recruiting· Phase 3
HPV vaccine study for Chinese women, ages 9–45

This trial tests an 11-type HPV vaccine to prevent infection from multiple HPV strains. If you enroll, you’ll receive scheduled vaccine doses and have health and gynecologic check-ins to see how well the vaccine works and is tolerated.

Hechi, Guangxi
NCT06220747Recruiting
HPV vaccine study for women ages 12 to 45

This study tests how well the HPV vaccine works in women and teens. It's for those who are willing to get an HPV test and haven't already had all 3 doses of the vaccine.

Bangkok, Select...

Hear when a new Human Papilloma Virus Infection Type 16 trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.